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Abstract
Huntington’s disease (HD) is caused by the expansion of N-terminal polymorphic poly Q stretch of the protein huntingtin
(HTT). Deregulated microRNAs and loss of function of transcription factors recruited to mutant HTT aggregates could cause
characteristic transcriptional deregulation associated with HD. We observed earlier that expressions of miR-125b, miR-146a
and miR-150 are decreased in STHdh
Q111/Hdh
Q111 cells, a model for HD in comparison to those of wild type STHdh
Q7/Hdh
Q7
cells. In the present manuscript, we show by luciferase reporter assays and real time PCR that decreased miR-146a
expression in STHdh
Q111/Hdh
Q111 cells is due to decreased expression and activity of p65 subunit of NFkB (RelA/NFkB). By
reporter luciferase assay, RT-PCR and western blot analysis, we also show that both miR-150 and miR-125b target p53. This
partially explains the up regulation of p53 observed in HD. Elevated p53 interacts with RelA/NFkB, reduces its expression
and activity and decreases the expression of miR-146a, while knocking down p53 increases RelA/NFkB and miR-146a
expressions. We also demonstrate that expression of p53 is increased and levels of RelA/NFkB, miR-146a, miR-150 and miR-
125b are decreased in striatum of R6/2 mice, a mouse model of HD and in cell models of HD. In a cell model, this effect
could be reversed by exogenous expression of chaperone like proteins HYPK and Hsp70. We conclude that (i) miR-125b and
miR-150 target p53, which in turn regulates RelA/NFkB and miR-146a expressions; (ii) reduced miR-125b and miR-150
expressions, increased p53 level and decreased RelA/NFkB and miR-146a expressions originate from mutant HTT (iii) p53
directly or indirectly regulates the expression of miR-146a. Our observation of interplay between transcription factors and
miRNAs using HD cell model provides an important platform upon which further work is to be done to establish if such
regulation plays any role in HD pathogenesis.
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Introduction
Huntington’s disease (HD) is an autosomal dominant neurode-
generative disorder caused by the expansion of polymorphic CAG
repeats in exon1 of Huntingtin (HTT ) gene. Among various
molecular and cellular dysfunctions originated from mutations to
HTT gene, which eventually lead to neuronal loss from striatal
regions in HD patients, transcriptional deregulation is considered to
be one of the important events [1,2]. Such deregulation of genes has
beenattributed, at least partially, to interactions and recruitments of
several transcription factors to the mutant HTT aggregates [2,3].
Transcription factors (TFs) like TBP, CBP, p53, Sp1, NFkB and
others are recruited to aggregates formed by mutant HTT, the
hallmark of HD [4–9]. Functional consequence of such recruitment
remains largely unknown. Recruitment of TFs to the aggregates
may result in loss of functions of the TFs. This can explain the
altered expressions of many genes in HD [2,3]. In the presence of
mutated HTT exon1, repression of transcription from p53-
responsive promoters is detected, indicating hypo function of p53
in HD [8]. However, the level of p53 is increased in various models
of HD as well as in the affected tissue in HD patients possibly due to
post transcriptional or post-translational modifications [4]. It has
also been shown that p53 directly interacts with the promoter
sequence of HTT gene that harbors multiple p53 response elements
[10]. Increased expression of mutant HTT due to higher level of
p53 in turn may increase the aggregates formed by mutant HTT.
Direct evidence that p53 participates in the pathogenesis of HD is
also available [11]. However, effects of recruitment and interaction
of NFkB withmutant HTT in HD pathogenesis remains unclear. In
a cell model of HD, it has been shown that NFkB activity is
increased in the early stage when there are no visible aggregates of
mutant HTT, while at a later stage when visible aggregates are
formed, NFkB activity is reduced [12]. Similar decrease in NFkB
activity after 72 hours of induction of mutant HTT was also
observed in a cell model of HD, while in early stage of induction,
NFkB activity was increased [13,14]. This dual role of mutant HTT
on NFkB activity could be due to initial protective action of NFkB,
which is suppressed at a later stage by the recruitment of NFkB into
the aggregates. Alteration of NFkB activity may result in altered
expression of NFkB regulated genes.
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23837Micro RNA (miRNA) belongs to a class of small non-coding
single stranded RNA, approximately 21 nucleotides long, and
generally regulates gene expression negatively. Mature miRNA
interacts mostly with 39 untranslated regions (39UTRs) of the
genes in human and down regulates the expression of the targets
either by degrading the mRNAs or by inhibiting their translation.
In some cases, increased expression of target genes by miRNAs
have also been reported [15]. Recent experiments show that at
least in few specific cases, mature miRNA can alter the expression
of genes even by binding to the coding regions as well as to the 59
UTRs of its targets [16,17,18]. It thus provides further complex
regulation of genes by miRNAs. It has been proposed on the basis
of theoretical analysis that as many as 30% of genes in the human
genome may be the targets of miRNAs [19]. However, latter
estimates predict that as large as 90% of human genes are targets
of miRNAs [20], although experimentally validated targets are
limited. MiRNA genes are regulated in similar way as that of
coding genes [21,22]. For example, p53 is known to increase as
well as decrease the expression of several miRNAs [23–27].
Interestingly, p53 is one of the targets of miR-125b [28], which is
itself negatively regulated by p53 [26]. RelA/NFkB regulates the
expression of miR-146a [29]. The neuron-restrictive silencer
factor (NRSF), also known as Repressor Element Silencing
Transcription Factor (REST), another HTT interacting protein,
regulates several miRNAs. Among them, miR-132, miR-124,
miR-9 and miR-9* are down regulated in affected tissues of HD
patients [30,31]. To investigate whether miRNA expressions are
altered in HD, we recently identified changes in expressions of
several miRNAs in STHdh
Q111/Hdh
Q111 cells, a cell model of HD.
We also characterized that miR-146a which is down regulated in
the cell model targets TBP [32,33].
As RelA/NFkB regulates the expression of miR-146a [29], in
the present manuscript, we first tested the hypothesis that down
regulation of miR-146a could be due to decreased activity of NFkB
in STHdh
Q111/Hdh
Q111 cells. Further, we tested whether p53 is a
target of miRNAs, which are down regulated in STHdh
Q111/
Hdh
Q111 cells [33]. We then focused on the regulation of miR-146a
by both RelA/NFkB and p53. We observed that NFkB activity is
compromised in STHdh
Q111/Hdh
Q111 cells and exogenous expres-
sion of p65 sub-unit of NFkB i.e. RelA/NFkB increased the
expression of mature miR-146a in STHdh
Q111/Hdh
Q111 cells. In
addition, we showed that increased level of p53 in STHdh
Q111/
Hdh
Q111 cells could be due to decreased level of miR-150 and
miR-125b. Besides, we also showed that exogenous p53 decreased
the expression of RelA/NFkB and also reduced NFkB activity.
Besides, p53 directly or indirectly regulated the expression of miR-
146a. Further, results obtained with mutant HTT aggregates led
us to postulate that in the presence of the aggregates there is an
initial decrease in miR-125b and miR-150 expression. These
down regulated miRNAs lead to increased p53 level. Elevated p53
then in turn, may decrease RelA/NFkB expression, NFkB activity
and miR-146a expression.
Results






We have shown earlier that expressions of several miRNAs are
altered in STHdh
Q111/Hdh
Q111 cells in comparison with STHdh
Q7/
Hdh
Q7 cells. Among the altered miRNAs, miR-146a is down
regulated [33]. It is known that RelA/NFkB regulates the
expression of miR-146a [29]. To investigate the possible role of
RelA/NFkB in the observed down regulation of miR-146a in
STHdh
Q111/Hdh
Q111 cells, we first determined the steady state level
(expression) of p65 sub-unit of NFkB i.e. RelA/NFkB in these cells.
Western blot analysis revealed that the expression of RelA/NFkB
(denoted by p65 in Figure 1A) was indeed decreased significantly
(n=3, p=0.018) in STHdh
Q111/Hdh
Q111 cells in comparison with
that in STHdh
Q7/Hdh
Q7 cells (Figures 1A and 1B). Using
luciferase reporter assay with multiple NFkB responsive elements
(denoted as NFkB-RE), we further observed that NFkB activity
was also significantly (n=4, p=0.0082) compromised in
STHdh
Q111/Hdh
Q111 cells (Figure 1C). This was further con-
firmed by using gastrin promoter tagged reporter luciferase activity
assay. It is known that RelA/NFkB regulates gastrin gene
expression [34]. This result shown in Figure 1D confirms that




Given that RelA/NFkB regulates miR-146a expression [29] and
above observations that both RelA/NFkB steady state level and
activity are compromised in STHdh
Q111/Hdh
Q111 cells, we tested
whether exogenous expression of p65 sub-unit of NFkB (RelA/
NFkB) could rescue the expression of miR-146a in these cells.





Q111 cells increased the
expression of the gene as determined by western blot analysis. In
such condition, NFkB activity as revealed by reporter luciferase
assay, was also increased significantly (n=4, p=0.022) as shown in
Figure 2B. Mature miR-146a expression was increased in such
condition in both STHdh
Q7/Hdh
Q7 cells (n=3, p=0.036) and
STHdh
Q111/Hdh
Q111 cells (n=3, p=0.045) as shown in Figure
2C. Even though miR-146a expression increased in STHdh
Q111/
Hdh
Q111 cells exogenously expressing RelA/NFkB in comparison
to STHdh
Q111/Hdh
Q111 cells with endogenous RelA/NFkB, it did
not rescue up to the level observed in STHdh
Q7/Hdh
Q7 cells. It is
known that aspirin decreases NFkB activity [35]. We thus tested
whether decreasing NFkB activity by aspirin could alter miR-146a
expression. STHdh
Q7/Hdh
Q7 cells treated with 2.0 mM aspirin for
24 hours decreased the basal NFkB activity significantly (n=2,
p=0.014) (Figure 2B). In such condition, expression of miR-146a
was significantly (n=2, p=0.031) reduced (Figure 2D). Taken
together, we show that increasing the expression of RelA/NFkB in
STHdh
Q111/Hdh
Q111 cells increased miR-146a expression and
reducing the expression of RelA/NFkB decreased miR-146a
expression in STHdh
Q7/Hdh
Q7 cells establishing that decreased
RelA/NFkB expression could result in the decreased expression of
miR-146a.
Over expression of p53 in STHdh
Q111/Hdh
Q111 cells: role
of miR-125b and miR-150
Expression of p53 is increased in STHdh
Q111/Hdh
Q111 cells [32]
as well as in various models of HD and post mortem HD brains.
The exact mechanism for the increase of p53 protein in HD
remains unknown. It has been shown by us that miR-125b is down
regulated in STHdh
Q111/Hdh
Q111 cells compared to the wild type
cells [33]. Given that p53 is a validated target of miR-125b [28],
we explored whether increased expression level of endogenous p53
in STHdh
Q111/Hdh
Q111 cells could be due to decrease in the
expression of miR-125b or any other miRNA down regulated in
these cells [33]. We confirmed that the endogenous expression of
p53 is increased in STHdh
Q111/Hdh
Q111 cells (Figures 3A and
3B) compared to the wild type STHdh
Q7/Hdh
Q7 cells. Luciferase
activity of the reporter vector pmiR-Report with 150 bp (position
733–739) of the 39-UTR of human p53 (p53-UTR1) containing
miR-125b recognition site [28] was also significantly (n=3,
p=0.026) increased in STHdh
Q111/Hdh
Q111 cells compared to
that observed in STHdh
Q7/Hdh
Q7 cells (Figure 3C) indicating that
down regulated miR-125b could target p53 and increase its
Regulation of miR-146a in Huntington’s Disease
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increased the expression of mature miR-125b significantly (data
not shown) decreased reporter luciferase activity significantly in
STHdh
Q7/Hdh
Q7 cells (n=3, p=0.024) and STHdh
Q111/Hdh
Q111
cells (n=3, p=0.0086) when co-expressed with p53-UTR1
(Figure 3D). In addition, exogenous expression of miR-125b
decreased the endogenous expression of p53 (n=3, p=0.039),
shown in Figure 3E. Taken together, these results confirmed the
earlier observation that p53 is one of the targets of miR-125b [28].
Thus, the increased expression level of endogenous p53 in
STHdh
Q111/Hdh
Q111 cells could be due to decreased expression
of endogenous miR-125b.
We searched mirbase [36] (http://www.mirbase.org/) and
observed that human p53 could also be targeted by miR-150,
which is decreased in STHdh
Q111/Hdh
Q111 cells [33]. We cloned
136 bp (position 234–256) of the 39-UTR of p53 (p53-UTR2)




Q7 cells. (A) Representative Western Blot showing
decreased level of RelA/NFkB (denoted by p65 in the figure) in STHdh
Q111/Hdh
Q111 cells compared to STHdh
Q7/Hdh
Q7 cells; (B) Average integrated
optical density (IOD) of p65 protein bands (RelA/NFkB) in A, normalized to b-actin level (n=3, p=0.018) in these cells; (C) Average luciferase activity
using reporter luciferase with multiple NFkB response elements (denoted by NFkB-RE) in STHdh
Q111/Hdh
Q111 cells compared to STHdh
Q7/Hdh
Q7 cells.
Normalization of protein level between STHdh
Q7/Hdh
Q7 cells and STHdh
Q111/Hdh
Q111 cells was done by taking the ratio of Relative Luciferase Units
(RLU) of NFkB-RE and empty vector pGL3 in these cells. The normalized value obtained with STHdh
Q7/Hdh
Q7 cells was taken as 1. Relative luciferase
activity of NFkB-RE was found significantly lower (n=4, p=0.0082) in STHdh
Q111/Hdh
Q111 cells compared to STHdh
Q7/Hdh
Q7 cells; (D) Average reporter
luciferase activity with Gastrin promoter (n=2, p=0.034) in STHdh
Q7/Hdh
Q7 cells and STHdh
Q111/Hdh
Q111 cells. Normalization of protein level between
the cells was done by taking the ratio of Relative Luciferase Units (RLU) of Gastrin promoter construct and empty vector pGL3 in these cells. The
normalized value obtained with STHdh
Q7/Hdh
Q7 cells was taken as 1; Error bars represent standard deviation s of more than 2 experiments and each
experiment was done in duplicate. ‘‘*’’ represents statistical significance; * p#0.05; ** p,0.01.
doi:10.1371/journal.pone.0023837.g001
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luciferase reporter vector as described above. We observed
that the luciferase activity of the reporter with p53 39-UTR
containing the recognition site of miR-150, shown in Figure
S1 (A), was increased significantly (n=3, p=0.031) in
STHdh
Q111/Hdh
Q111 cells compared to that in STHdh
Q7/Hdh
Q7




Q111 cells. (A) Western Blot showing increased p65
protein (RelA/NFkB) level in (i) STHdh
Q7/Hdh
Q7 cells expressing exogenous p65 subunit of NFkB (RelA/NFkB) compared to control STHdh
Q7/Hdh
Q7 cells
and in (ii) STHdh
Q111/Hdh
Q111 cells expressing exogenous p65 subunit of NFkB (RelA/NFkB) compared to the control STHdh
Q111/Hdh
Q111 cells; (B)
Average luciferase activity of NFkB response element (NFkB-RE) in STHdh
Q7/Hdh
Q7 cells and STHdh
Q7/Hdh
Q7 cells expressing exogenous p65 subunit
of NFkB (RelA/NFkB). Exogenous expression of p65 sub-unit of NFkB (RelA/NFkB) increased the luciferase activity significantly (n=4, p=0.022). Bars3
and 4, from the left, represent changes in luciferase activity of NFkB-RE on treatment with 0.1 mM and 2 mM aspirin for 24 hours in STHdh
Q7/Hdh
Q7
cells. Treatment with 2.0 mM aspirin reduced the luciferase activiy (n=2, p=0.014); (C) Fold increase in the expression of mature miR-146a detected
by real time PCR using stem loop specific primers in p65 subunit of NFkB (RelA/NFkB) transfected STHdh
Q7/Hdh
Q7 cells (n=3, p=0.036) and
STHdh
Q111/Hdh
Q111 cells (n=3, p=0.045). Expression of miR-17-5p was used as endogenous control. Expression of miR-146a was significantly higher
in cells expressing p65 subunit of NFkB (RelA/NFkB); (D) Treatment with 2.0 mM aspirin decreased the expression of mature miR-146a in STHdh
Q7/
Hdh
Q7 cells (n=2, p=0.031). Error bars represent standard deviation s of more than 2 experiments and each experiment was done in duplicate.
‘‘*’’ represents statistical significance; * p#0.05; ** p,0.01.
doi:10.1371/journal.pone.0023837.g002
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target p53. We next cloned pre-miR-150 in pRNA-U61 vector.
STHdh
Q111/Hdh
Q111 cells transfected with this construct showed
an increase in mature miR-150 levels as detected by Real Time
PCR with stem loop specific primers. The result shown in
Figure 4B was statistically significant (n=3, p=0.0056).
Exogenous expression of cloned pre-miR-150 construct de-
creased the reporter luciferase activity of p53-UTR2 in both
STHdh
Q7/Hdh
Q7 (n=3, p=0.021) and STHdh
Q111/Hdh
Q111
cells (n=3, p=0.040) as shown in Figure 4C. Moreover, over
expression of pre-miR-150 decreased the endogenous expres-
sion of p53 in STHdh
Q111/Hdh
Q111 cells (n=3, p=0.043) as
shown by Western blot analysis (Figure 4D). These results
indicate that p53 could be targeted by miR-150 as well.




Q111 cells: decreased miR-125b target p53. (A)
Representative Western Blot showing increased p53 protein level in STHdh
Q111/Hdh
Q111 cells compared to STHdh
Q7/Hdh
Q7 cells; (B) Average
integrated optical density (IOD) of p53 protein bands in A, normalized to b-actin level (n=3, p=0.024) in these cell lines. (C) Relative luciferase activity
of cloned p53-39UTR with miR-125b binding site (denoted by p53-UTR1) in STHdh
Q111/Hdh
Q111 cells compared to STHdh
Q7/Hdh
Q7 cells. Normalization
of protein level between STHdh
Q111/Hdh
Q111 cells and STHdh
Q7/Hdh
Q7 cells was done by taking the ratio of RLU of cloned construct i.e. p53-UTR1 and
empty vector pmiR. Relative luciferase activity of p53-UTR1 was found significantly higher (n=3, p=0.026) in STHdh
Q111/Hdh
Q111 cells compared to
STHdh
Q7/Hdh
Q7 cells; (D) Reduced luciferase activity of p53-UTR1 co-transfected with pre-miR-125b in STHdh
Q7/Hdh
Q7 cells (n=3, p=0.024) and
STHdh
Q111/Hdh
Q111 cells (n=3, p=0.0086) compared to those obtained in respective empty vector U61 tansfected cells; (E) Representative Western
Blot showing reduction in p53 protein level in STHdh
Q111/Hdh
Q111 cells 72 hours following transfection with pre-miR-125b compared to STHdh
Q111/
Hdh
Q111 cells transfected with empty vector U61, average IOD compared to b-actin (n=3, p=0.039) is shown in the adjacent bar diagram.
doi:10.1371/journal.pone.0023837.g003
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39 UTR) ofp50sub-unit ofNFkB (alsoknown asNFkB1)containing
no predicted recognition sites for either miR-125b or miR-150 and
did not observe any change in the luciferase activity significantly
when the construct (p50-UTR) was co-transfected with cloned pre-
miR-125b or pre-miR-150 in STHdh
Q7/Hdh
Q7 cells (Figure 5A).
This result showed that the decrease in the luciferase activity by
exogenous expression of miR-150 was specific. Although endoge-




Q111 cells. (A) Relative luciferase activity of cloned p53-
39UTR with miR-150 binding site (denoted by p53-UTR2) in STHdh
Q111/Hdh
Q111 cells compared to STHdh
Q7/Hdh
Q7 cells. Normalization of protein levels
between the cells was done as described earlier. Relative luciferase activity of p53-UTR2 was found significantly higher (n=3, p=0.031) in STHdh
Q111/
Hdh
Q111 cells compared to STHdh
Q7/Hdh
Q7 cells; (B) Fold increase (n=3, p=0.0056) in mature miR-150 expression detected by real time PCR using
stem loop specific primers in STHdh
Q111/Hdh
Q111 cells transfected with cloned pre-miR-150 compared to STHdh
Q111/Hdh
Q111 cells transfected with
empty vector U61, at 24 hours post transfection. Expression of miR-17-5p was used as endogenous control; (C) Reduced luciferase activity of p53-
UTR2 co-transfected with pre-miR-150 in STHdh
Q7/Hdh
Q7 cells (n=3, p=0.021) and STHdh
Q111/Hdh
Q111 cells (n=3, p=0.04) compared to those
obtained in respective empty vector U61 transfected cells; (D) Typical Western Blot showing reduction in p53 protein level in STHdh
Q111/Hdh
Q111 cells
72 hours following transfection with pre-miR-150 compared to STHdh
Q111/Hdh
Q111 cells transfected with empty vector U61. Average IOD compared
to b-actin (n=3, p=0.043) is shown in the adjacent bar diagram.
doi:10.1371/journal.pone.0023837.g004
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150, there was no change in p53 level either in the presence of
exogenous miR-19a or miR-146a (Figure 5B and 5C). Neither of
these miRNAs has any predicted recognition site in the cloned
39UTRs of p53 as revealed from miRbase. Taken together, these
results show that p53 is specifically targeted by miR-125b and miR-
150. Since the expressions of miR-125b and miR-150 were
decreased in STHdh
Q111/Hdh
Q111 cells compared to those obtained
in STHdh
Q7/Hdh
Q7 cells, we expressed these miRNAs in
STHdh
Q111/Hdh
Q111 cells and detected the endogenous expression
of p53 as shown in Figure 5D. It is evident that exogenous
expressions of both the miRNAs resulted in decreased expression of
p53 in STHdh
Q111/Hdh
Q111 cells. However, the level of expression
did not reach exactly up to that of in STHdh
Q7/Hdh
Q7 cells. Thus,
decreased expressions of miR-125b and miR-150 in STHdh
Q111/
Hdh
Q111 cells could result in increased expression of p53.






There are conflicting results regarding the functional interac-
tions between RelA/NFkB and p53. Several reports show that p53
inhibits the transcriptional activity of RelA/NFkB [37–40] either
by binding to the promoter sequences or by altering the
interaction of NFkB with p53 and CBP. A different pathway has
been identified where p53 enhances RelA/NFkB activity [41,42].
These observations prompted us to find whether increased
expression of p53 in STHdh
Q111/Hdh
Q111 cells had any influence
on the down regulation of miR-146a. We exogenously expressed
p53 in STHdh
Q7/Hdh
Q7 cells and knocked down p53 in
STHdh
Q111/Hdh
Q111 cells and also in STHdh
Q7/Hdh
Q7 cells using
validated siRNA commercially available from Imgenex Corpora-
tion. Exogenous expression of p53 in STHdh
Q7/Hdh
Q7 cells was
confirmed by RT-PCR Figure 6A (i) as well as by western blot
analysis Figure 6A (ii) while down regulation of the protein by
siRNA in STHdh
Q7/Hdh
Q7 cells was confirmed by western blot
analysis as shown in Figure 6B. Detection of the expression of
mature miR-146a in these cells revealed that in the presence of
exogenous p53, miR-146a was down regulated significantly (n=3,
p=0.032) while as expected, knocking down p53 up regulated the
expression of the miRNA (n=3, p=0.029) as shown in Figure
6C.
To confirm further, we treated STHdh
Q7/Hdh
Q7 cells with 5-
Flurouracil (5-FU, 10 mg/ml for 12 h and 18 h), which is known to
stabilize p53 protein [43]. In such condition, steady state level of
p53 was increased (Figure 7A) and the expression of miR-146a
was decreased significantly for both the time points as shown in
Figure 7B. As we have shown above that miR-150 might target
p53, we also expressed miR-150 in STHdh
Q111/Hdh
Q111 cells and
as expected, significant increase (n=3, p=0.039) in the expression
of miR-146a was observed (Figure 7C), possibly due to down
regulation of p53 by miR-150. Similar increase in miR-146a
expression was observed when STHdh
Q7/Hdh
Q7 cells were
transfected with miR-150. However, when p53 was co-transfected
with miR-150, no increase in the expression of miR-146a was
observed. This result shows that decrease in p53 expression by
miR-150 could be compensated here by the exogenous expression
of p53 which does not have the 39-UTR region bearing the target
site of miR-150. Indeed miR-146a was down regulated when p53
was co-transfected with miR-150. However, the extent of decrease
was less compared to when STHdh
Q7/Hdh
Q7 cells were transfected
with p53 alone as shown in Figure 7D. These results showed that
in our experimental conditions, p53 directly or indirectly regulates
the expression of miR-146a.
Regulation of p65 subunit of NFkB (RelA/NFkB)
expression and activity by exogenous p53
It has been mentioned in the preceding section that there are
conflicting results regarding the functional interactions between
RelA/NFkB and p53. This conflicting result could arise from the
dependence of cellular needs in different conditions of growth as
well as for different types of cells. Depending on cellular needs, p53
may modulate NFkB activity differently. We tested whether p53
directly or indirectly regulates NFkB (RelA/NFkB) expression and
activity. Exogenous expression of p53 significantly (n=3,
p=0.041) reduced the steady state level of RelA/NFkB) in
STHdh
Q7/Hdh
Q7 cells (Figure 8A). Exogenous expression of p53
in STHdh
Q7/Hdh
Q7 cells significantly decreased (n=3, p=0.021)
the activity of NFkB whereas knocking down p53 by siRNA led to
an increase in NFkB activity (n=3, p=0.032) in STHdh
Q7/Hdh
Q7
cells. Reduction of p53 expression in STHdh
Q111/Hdh
Q111 cells by
expressing miR-150 that targets p53, significantly increased NFkB
activity (n=4, p=0.0482) as detected by luciferase reporter assay
(Figure 8B). Similar results were also obtained in HeLa cells
expressing exogenous p53 and by knocking down p53 by siRNA
(data not shown). Thus, in the presence of excess p53, RelA/NFkB
expression and activity are reduced. This result showed that
increased p53 in STHdh
Q111/Hdh
Q111 cells might reduce NFkB
activity. Besides, there are evidence of physical interaction
between (RelA/NFkB) and p53 [37]. By co-immuno precipitation





Q111 cells (Figure 8C). However, it remains
unknown how p53 negatively regulates RelA/NFkB expression.
Poly Q aggregates cause alterations in the expressions of
protein coding genes and miRNAs and removal of
aggregates by chaperones rescue such changes
Formation of mutant HTT aggregates is the hallmark of HD
and has been shown in several studies using cell [44] and animal
models of HD as well as in the post mortem brains of HD patients.
Recently, we have shown that HYPK, an interacting partner of
HTT, possesses chaperone like activity and reduces mutant HTT
aggregates and toxicity [45]. Besides, other chaperones including
Hsp70 reduce mutant HTT aggregates [46]. Expression of DsRed
tagged N-terminal HTT with 83Q coded by exon1 of HTT gene
in STHdh
Q7/Hdh
Q7 cells increased mutant HTT aggregates and in
the presence of exogenous HYPK such aggregates are reduced
(data not shown), similar to that which has been published earlier
by us in other neuronal cells [44]. Expression of p53 was increased
and RelA/NFkB expression was decreased (Figure 9A) in the
presence of aggregates as revealed by RT-PCR. In such
conditions, NFkB activity as determined by reporter luciferase
assay was significantly (n=6, p=0.0334) decreased (Figure 9B).
Expression of miR-146a was also significantly (n=4, p=0.011)
decreased along with the expression of miR-125b and miR-150 as
shown in Figure 9C, similar to that which has been shown in
STHdh
Q111/Hdh
Q111 cells [33]. HYPK-GFP and Hsp70-GFP were
transfected into the cells which increased the level of HYPK and
Hsp70 respectively as shown by Western blot analysis in Figure
9D.
Interestingly, when 83Q was co-transfected with HYPK-GFP or
Hsp70-GFP in STHdh
Q7/Hdh
Q7 cells, p53 expression was decreased
and RelA/NFkB expression was recovered in comparison to that
obtained in STHdh
Q7/Hdh
Q7 cells expressing only mutant HTT
exon1 (Figure 10A and 10B). NFkB activity was also significantly
increased in such conditions in presence of HYPK-GFP (n=6,
p=0.031) and Hsp70-GFP (n=6, p=0.029) in 83Q-DsRed
transfected STHdh
Q7/Hdh
Q7 cells (Figure 10C). Moreover, remov-
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PLoS ONE | www.plosone.org 7 August 2011 | Volume 6 | Issue 8 | e23837Figure 5. p53 is specifically targeted by miR-125b and miR-150 in HD cell model. (A) No change in relative luciferase activity of p50-39UTR
(bearing no predicted recognition site for miR-125b or miR-150) in cells co-transfected with pre- miR-125b and pre-miR-150 compared to cells co-
transfected with empty vector U61; (B) RT-PCR showing (i) reduction in p53 mRNA in cells expressing exogenous pre-miR-150 and pre-miR-125b
compared to cells expressing empty vector U61, (ii) no reduction in p53 mRNA in cells expressing exogenous pre-miR-19a and pre-miR-146a
compared to cells expressing empty vector U61. (C) Average IOD showing relative expression of p53 mRNA in presence of over expressed miR-150
(n=2, p=0.021), miR-125b (n=2, p=0.029), miR-19a and miR-146a is given in the adjacent bar diagram (negative control). This indicates that p53 is





Q111 and in STHdh
Q111/Hdh
Q111 cells transfected with miR-125b or miR-150. Immunoblot analysis show
that the extent of p53 up regulation found in STHdh
Q111/Hdh
Q111 cells when compared to STHdh
Q7/Hdh
Q7 cells was reduced when STHdh
Q111/Hdh
Q111
cells were transfected with miR-125b or miR-150.
doi:10.1371/journal.pone.0023837.g005
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miR-146a, miR-125b and miR-150 (Figure 10D). It is to be noted
that the ability to recover the expressions of miR-125b, miR-146a
and miR-150 by Hsp70 was higher compared to that obtained with
HYPK, reasons remaining unknown. This result shows that mutant
HTT aggregates directly or indirectly increased p53 expression,
reduced RelA/NFkB expression and activity and also reduced miR-
146a, miR-125b and miR-150 expressions.
Expressions of p53, RelA/NFkB, miR-125b, miR-146a and
miR-150 in striatal region of the brains of R6/2 mice
Transgenic mice (R6/2 strain), an animal model of HD [47] has
been widely used by many investigators. Total RNA was isolated
from paraffinised tissue sections of these R6/2 mice and their age-
matched controls as described in the materials and methods
section. cDNA was prepared using random hexamer to determine
the expressions of p53 and RelA/NFkB in the striatal tissues.
Figure 6. Role of p53 in the expression of miR-146a. (A) (i) RT-PCR showing p53 over expression upon transfection of exogenous p53-CFP in
STHdh
Q7/Hdh
Q7 cells compared to cells transfected with empty vector CFP and (ii) western blot showing p53 over expression at the protein level
under similar conditions; (B) Representative Western Blot showing reduction in p53 protein level in STHdh
Q7/Hdh
Q7 cells trasfected with
pSuppressor plasmid containing p53 siRNA construct compared to STHdh
Q7/Hdh
Q7 cells transfected with empty vector U61. Average IOD showing
significant reduction in p53 protein level (n=3, p=0.041) compared to that of b-actin (control) is shown in the adjacent bar diagram; (C) Fold
change in miR-146a expression in STHdh
Q7/Hdh
Q7 cells in presence of over expressed p53 and reduced p53 levels respectively. miR-146a expression
was significantly decreased (n=3, p=0.032) in STHdh
Q7/Hdh
Q7 cells 72 hours post transfection with p53-CFP compared to empty vector CFP
transfected cells and the expression was increased (n=3, p=0.029) in STHdh
Q7/Hdh
Q7 cells compared to control STHdh
Q7/Hdh
Q7 cells transfected
with empty vector U61.
doi:10.1371/journal.pone.0023837.g006
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increased significantly (n=3, p=0.05), while the expression of
RelA/NFkB was decreased significantly (n=3, p=0.04) compared
to control (Figure 11A). As described above similar result was
obtained in cell models of HD (Figures 1A, 3A and 9A). Besides,
cDNA prepared using stem-loop specific primers for mature miR-
125b, miR-146a and miR-150 also revealed a decrease in the
expressions of these miRNAs (n=3, p,0.01), similar to that
Figure 7. Stabilisation of p53 by 5-FU in STHdh
Q7/Hdh
Q7 cells leads to decreased expression of miR-146a. (A) Typical Western Blot




Q7 cells were treated with 10 mg/ml of 5-FU. Cells were harvested
12 hours and 18 hours successively post 5-FU treatment and immunoblotting with the cell extracts show an up regulation in p53 protein level in the
treated cells compared to the untreated ones; (B) miR-146a expression was reduced significantly in STHdh
Q7/Hdh
Q7 cells treated with 5-FU for
12 hours (n=2, p=0.038) and for 18 hours (n=2, p=0.0089) compared to the respective untreated cells; (C). Relative differences in miR-146a
expression in presence of reduced p53 levels in STHdh
Q111/Hdh
Q111 cells. miR-146a expression was increased significantly (n=3, p=0.039) in
STHdh
Q111/Hdh
Q111 cells 72 hours post transfection with pre-miR-150 compared to STHdh
Q111/Hdh
Q111 cells transfected with empty vector U61. (D)
Relative differences in miR-146a expression in endogenous STHdh
Q7/Hdh
Q7 cells and in cells transfected respectively with pre-miR-150, p53 and pre-
miR-150 and p53 alone. Mature miR-146a expression was increased significantly (n=3, p=0.03) in cells transfected with pre-miR-150 which has been
shown to reduce p53. miR-146a expression was reduced in presence of p53 (n=3, p=0.032). However, the reduction was less in cells when p53 was
co-transfected with pre-miR-150 (n=3, p=0.044).
doi:10.1371/journal.pone.0023837.g007
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PLoS ONE | www.plosone.org 10 August 2011 | Volume 6 | Issue 8 | e23837Figure 8. Regulation of RelA/NFkB expression and activity by p53. (A) Typical experiment by Western Blot showing decrease in NF-kB (p65)
i.e. RelA/NFkB expression upon over expression of p53 in STHdh
Q7/Hdh
Q7 cells. RelA/NFkB expression was decreased significantly (n=3, p=0.0041) in
STHdh
Q7/Hdh
Q7 cells 48 hours post transfection with p53-CFP compared to STHdh
Q7/Hdh
Q7 cells transfected with empty vector CFP. Average IOD
obtained by comparing with b-actin is shown in the adjacent bar diagram; (B) Decrease in luciferase activity (n=3, p=0.0214) of NFkB-RE in STHdh
Q7/
Hdh
Q7 cells 48 hours post transfection with p53-CFP compared to STHdh
Q7/Hdh
Q7 cells transfected with empty vector CFP and increase in luciferase
activity (n=3, p=0.032) of NFkB-RE in STHdh
Q7/Hdh
Q7 cells 48 hours post transfection with p53 si compared to control STHdh
Q7/Hdh
Q7 cells; increase
in luciferase activity (n=4, p=0.0482) of NFkB-RE in STHdh
Q111/Hdh
Q111 cells 48 hours post transfection with pre-miR-150 compared with that
obtained in STHdh
Q111/Hdh
Q111 cells transfected with empty vector U61. Relative luciferase activity of NFkB-RE obtained in control Q7 was taken as 1;





Q111 cells. Cell extracts prepared from STHdh
Q7/Hdh
Q7 cells and STHdh
Q111/Hdh
Q111 cells were immunoprecipitated by anti-p53
antibody coupled to agarose-protein G beads. Western blotting the p53 immunoprecipitated complex with anti-p65 antibody reveals such
interaction as evident in lanes 2 and 6 denoted by ‘+’ ve Ab.
doi:10.1371/journal.pone.0023837.g008
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PLoS ONE | www.plosone.org 11 August 2011 | Volume 6 | Issue 8 | e23837Figure 9. Poly Q aggregates alter the expressions of miR-125b, miR-150, p53, RelA/NFkB and miR-146a. (A) Increase in p53 expression
(n=3, p=0.028) and decrease in RelA/NFkB expression (n=3, p=0.031) in 83Q DsRed transfected STHdh
Q7/Hdh
Q7 cells compared to STHdh
Q7/
Hdh
Q7 cells transfected with empty vector DsRed. (B) Decrease in relative luciferase activity of NFkB-RE upon 83Q DsRed transfection in STHdh
Q7/
Hdh
Q7 cells. Average luciferase activity of NFkB-RE was significantly decreased (n=6, p=0.0334) in STHdh
Q7/Hdh
Q7 cells 48 hours post transfection
with 83Q DsRed compared to STHdh
Q7/Hdh
Q7 cells transfected with empty vector DsRed. (C) Similarly, miR-146a expression (n=4, p=0.011), miR-
125b expression (n=2, p=0.048) and miR-150 expressions (n=2, p=0.039) were decreased significantly in STHdh
Q7/Hdh
Q7 cells 48 hours post
transfection with 83Q DsRed compared to STHdh
Q7/Hdh
Q7 cells 48 hours post transfection with empty vector DsRed. miR-17-5p was used as
endogenous control to calculate fold change in each case; (D) Immunoblotting with cell extracts prepared from HYPK-GFP transfected STHdh
Q7/
Hdh
Q7 cells and Hsp70-GFP transfected STHdh
Q7/Hdh
Q7 cells showed increase in the expression of HYPK (in panel I probed by anti-HYPK antibody)
and Hsp70 (in panel II probed by anti-GFP antibody) respectively compared to those obtained in STHdh
Q7/Hdh
Q7 cells transfected with empty
vector GFP-C1.
doi:10.1371/journal.pone.0023837.g009
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PLoS ONE | www.plosone.org 12 August 2011 | Volume 6 | Issue 8 | e23837Figure 10. Removal of aggregates by chaperones rescue expression pattern of micoRNAs, p53 and RelA/NFkB. (A) RT-PCR showing
increase in p53 expression in STHdh
Q7/Hdh
Q7 cells co-transfected with 83Q DsRed and empty vector GFP-C1 (lane ii, n=3, p=0.028) and decrease in
p53 expression in STHdh
Q7/Hdh
Q7 cells co-transfected with 83Q DsRed and Hsp70-GFP (lane iii, n=3, p=0.025) and 83Q DsRed and HYPK-GFP (lane iv,
n=3, p=0.019) compared to control STHdh
Q7/Hdh
Q7 cells (lane i). Average IOD showing relative expression of p53 mRNA in each case is given in the
adjacent bar diagram. (B) Changes in p65 (RelA/NFkB) expression in STHdh
Q7/Hdh
Q7 cells co-transfected with 83Q DsRed and HYPK-GFP and 83Q
DsRed and Hsp70-GFP compared to STHdh
Q7/Hdh
Q7 cells co-transfected with 83Q DsRed and empty vector GFP-C1. The increase in RelA/NFkB
expression was significant in the presence of HYPK-GFP (n=6, p=0.028) and also in the presence of Hsp70-GFP (n=6, p=0.022). (C) Revival of
luciferase activity of NFkB-RE in presence of chaperones in 83Q DsRed transfected STHdh
Q7/Hdh
Q7 cells. Luciferase activity of NFkB-RE in STHdh
Q7/
Hdh
Q7 cells co-transfected with 83Q DsRed and HYPK-GFP was significantly increased (n=6, p=0.031) when compared to that obtained in STHdh
Q7/
Hdh
Q7 cells transfected with 83Q DsRed and empty vector GFP-C1. Similar increase (n=6, p=0.029) in relative luciferase activity of NFkB-RE was
observed in STHdh
Q7/Hdh
Q7 cells 48 hours post transfection with 83Q DsRed and Hsp70-GFP; (D) Similarly, miR-146a expression (n=3, p=0.033), miR-
125b expression and miR-150 expression were significantly increased in STHdh
Q7/Hdh
Q7 cells 48 hours post transfection with 83Q DsRed and HYPK-
GFP compared to STHdh
Q7/Hdh
Q7 cells transfected with 83Q DsRed and empty vector GFP-C1. Such increase in miR-146a expression (n=3,
p=0.0079), miR-125b expression and miR-150 expression were also observed with STHdh
Q7/Hdh
Q7 cells 48 hours post transfection with 83Q DsRed
and Hsp70-GFP. miR-17-5p was used as endogenous control to calculate fold change in each case.
doi:10.1371/journal.pone.0023837.g010
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Q111/Hdh
Q111 cells [33]. This result shown in
Figure 11B reveals that the alterations in the expressions of p53,
RelA/NFkB, miR-125b, miR-146a and miR-150 might be
involved in the pathogenesis of HD.
In order to see whether miR-146a, miR-125b and miR-150
were specifically down regulated than others in striatal region of
the brains of R6/2 mice, we determined the expression levels of
additional ten miRNAs in the mouse model and compared the
results with that obtained earlier by us in HD cell model [33]. The
results given in Table S1 show that expressions of miR-100, miR-
125b, miR-135a, miR-138, miR-150, miR-146a, miR-221 which
were decreased in HD cell model [33] were also decreased in R6/
2 mice and the expressions of miR-127-3p and miR-214 were
increased in both STHdh
Q111/Hdh
Q111 cells [33] and the R6/2
mouse model. miR-145, miR-148a, miR-190 and miR-335
however showed different expression pattern in R6/2 mice and
HD cell model [33]. Thus, out of the thirteen miRNAs whose
expressions have been studied, expressions of eight miRNAs
Figure 11. Expression pattern of p53, RelA/NFkB and microRNAs in striatal regions of the brains of R6/2 mice. (A) RT-PCR showing
expression levels of b-actin, p65 sub-unit of NFkB (RelA/NFkB) and p53 in striatal regions of the brains of R6/2 mice and their age matched controls.
Integrated optical density showing relative expression of p65 sub-unit of NFkB (RelA/NFkB) and p53 in the tissues normalized to b-actin are given in
the adjacent bar diagrams. RelA/NFkB expression was found to be lesser (n=3, p=0.041) and p53 expression greater (n=3, p=0.05) in striatum of
R6/2 mice when compared to their age matched controls. (B) Real time PCR analysis showing significant decrease in mature miR-150 expression
(n=3, p=0.01), mature miR-125b expression (n=3, p=0.002) and mature miR-146a expression (n=3, p=0.008) in striatum of R6/2 mice.
doi:10.1371/journal.pone.0023837.g011
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expressions of two miRNAs (viz., miR-127 and miR-214) were
increased and expressions of three miRNAs (viz., miR-145, miR-
190 and miR-335) remained unchanged in R6/2 mice. Earlier
observations by others showed miR-138, miR-218 and miR-222 to
be down regulated in HD mouse models [30,48] which had also
been confirmed by us in HD cell model [33].
We have already shown in the earlier section that Poly Q
aggregates cause decrease in the expressions of miR-146a, miR-
125b and miR-150 and removal of aggregates by chaperones
rescue such changes. To address the specificity of such alteration of
miR-146a, miR-125b and miR-150 in the presence of poly Q
aggregates, mutated exon1 of HTT gene that translated to N-
terminal HTT with 83 Q was exogenously expressed in four
different cell lines viz., Neuro2A (mouse neuroblastoma cell line),
STHdh
Q7/Hdh
Q7 (mouse sriatal cells having two copies of full
length HTT with 7Q), SH-SY5Y (human neuroblastoma cell line)
and HeLa cells (human cells derived from cervical tumours) and
the expression of twenty two miRNAs were studied in these cell
models (Table S1). Similar cell models of HD had earlier been
shown by us [44,45] and others. Of these twenty two miRNAs
taken for study, eleven miRNAs were earlier found to be up
regulated and eleven miRNAs were found to be down regulated by
us in HD cell model [33]. Among the up regulated miRNAs in
STHdh
Q111/Hdh
Q111 cells, expressions of miR-214, miR-299 and
miR-335 were also up regulated in three of the four cell models
and expression of miR-199a was increased in two cell models.
Expression of miR-148a, which was increased in STHdh
Q111/
Hdh
Q111 cells, was however decreased in all the four cell models.
Among the down regulated miRNAs, expression of miR-146a was
decreased in all the four cell models whereas expression of miR-
125b and miR-150 were decreased in three of the four cell models
excepting Neuro2A where expressions of those were up regulated.
Expressions of miR-100 and miR-135b were also decreased in two
of the four cell models. The results shown in Table S1 suggests
that although there is a heterogeneity in the expressions of
miRNAs in different cell lines exogenously expressing mutated
exon1 of HTT, miR-146a, miR-125b and miR-150 were
preferentially decreased than others in the presence of poly Q
aggregates.
A probable model showing the involvement of NFkB
(RelA), p53 and miRNAs in the regulation of cell death in
HD pathogenesis
The model shows that mutant HTT modulates the expressions
of both p53 and RelA/NFkB, NFkB activity and decreases miR-
146a, miR-125b and miR-150 expressions. In the presence of
mutant HTT aggregates, miR-125b and miR-150 expressions
decrease leading to an increased level of p53. The elevated p53
then in turn, further increases mutant HTT aggregates and
decreases RelA/NFkB expression, NFkB activity and miR-146a
expression.
Discussion
In this study, we present evidences to show that (i) in
STHdh
Q111/Hdh
Q111 cells decreased expression of miR-146a is
mediated through decreased expression and activity of RelA/
NFkB, (ii) increased expression of p53 in the same cells could be
due to decreased expression of miR-125b and miR-150, (iii) p53
and RelA/NFkB regulate the expression of miR-146a and (iv)
neuronal cells expressing N-terminal HTT with 83Q coded by
exon1 exhibit decreased miR-125b and miR-150 expressions,
increased p53 expression and reduced RelA/NFkB expression and
activity and miR-146a expression. Such changes could be rescued
by the expression of HYPK and Hsp70. Besides, we also show that
expressions of miR-125b, miR-146a, miR-150 and RelA/NFkB
were decreased while the expression of p53 was increased in
striatal tissues of R6/2 mice models of HD.
Transcription factor RelA/NFkB is known to regulate the
expression of miR-146a by binding to the upstream sequences
[29]. RelA/NFkB dependent increase in the expression of miR-
146a is shown earlier by several investigators in Alzheimer’s
disease (AD), viral infection, epilepsy and prion disease [49–52].
Increased expression of miR-146a results in the decreased
expression of complement factor H (CFH) in AD and Herpes
simplex virus type1 [49,50]. Even though elevated expression of
miR-146a is reported in epilepsy and scrapie, no targets of the
miRNA are reported. The reason for the difference in the
expression of the miRNA in AD and HD remains unknown. Here,
we show that the steady state level and activity of RelA/NFkB are
reduced in STHdh
Q111/Hdh
Q111 cells compared to those in
STHdh
Q7/Hdh
Q7 cells (Figures 1A–1D). Exogenous expression
of RelA/NFkB restores NFkB activity as well as the expression of
miR-146a (Figures 2A, 2B and 2C). Reducing the activity of
NFkB by treatment with aspirin [35] also compromised miR-146a
expression (Figure 2D). Taken together, the down regulation of
miR-146a in STHdh
Q111/Hdh
Q111 cells seen earlier [33] could be
due to lower steady state level of RelA/NFkB in these cells. We
then confirmed the earlier observation that the level of p53 is
increased in STHdh
Q111/Hdh
Q111 cells and also in other cell and
animal models of HD [10,11,32]. However, the mechanism of
such increased level of p53 was not known. Since p53 is a known
target of miR-125b [28] and the expression of miR-125b is down
regulated in STHdh
Q111/Hdh
Q111 cells [33], we tested the
hypothesis that increased expression of p53 in these cells could
be due to decreased level of miR-125b. Increased reporter
luciferase activity of human p53 39-UTR (718 to 742) containing
miR-125b recognition site viz., p53-UTR1 in STHdh
Q111/Hdh
Q111
cells compared to that in STHdh
Q7/Hdh
Q7 cells (Figure 3C) and
decreased luciferase activity of the same in presence of exogenous
miR-125b indicated that miR-125b could target p53 (Figure 3D).
Using the prediction tool RNAhybrid [53] http://bibiserv.techfak.
uni-bielefeld.de/rnahybrid/), we observed that mouse p53 (Trp53)
could also be targeted by miR-125b at 39-UTR position 413–435
as shown in Figure S1 (B). Exogenous expression of miR-125b
decreased the endogenous level of p53 in STHdh
Q111/Hdh
Q111 cells
(Figure 3E). These results confirmed that in STHdh
Q111/Hdh
Q111
cells, increased p53 level could be mediated by decreased
expression of miR-125b. Significant decrease of mature miR-150
was detected in STHdh
Q111/
Q111 cells compared to that obtained
in STHdh
Q7/Hdh
Q7 cells [33] and also in neuronal cells expressing
mutated exon1 of the HTT gene as well as in the post mortem
brain of HD mice R6/2. We confirmed the prediction that human
p53 could be a target of miR-150 at human p53 39-UTR position
234–256. Mouse p53 (Trp53) could also be a target of miR-150 at
39 UTR position 260–287 as shown in Figure S1 (C) using
RNAhybrid [53]. Increased expression of luciferase reporter with
predicted recognition site of miR-150 at the 39-UTR of human
p53 (p53-UTR2) in STHdh
Q111/Hdh
Q111 cells in comparison to
that in STHdh
Q7/Hdh
Q7 cells was observed (Figure 4A). In the
presence of exogenous miR-150, decreased expression of the same
luciferase reporter in STHdh
Q7/Hdh
Q7 cells (Figure 4C) and
reduction of endogenous p53 in STHdh
Q111/Hdh
Q111 cells (Figure
4D) were also observed. These results show that miR-150 also
targets p53. However, 213 bp (145–359) of the 39 UTR of NFkB1
(p50-UTR) containing no predicted binding site for either miR-
125b or miR-150 showed no change in its luciferase activity
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cloned pre-miR-125b or pre-miR-150 (Figure 5A). Although
endogenous p53 level was decreased by over expressing miR-125b
and miR-150, there was no change in p53 level either in the
presence of exogenous miR-19a or miR-146a (negative control),
which bears no predicted recognition site in the 39UTR of p53
(Figure 5B). Taken together, these results show that p53 is
specifically targeted by miR-125b and miR-150. Report that
expressions of miR-125b and miR-150 are decreased in
STHdh
Q111/
Q111 cells [33] and p53 is one of the targets of these
two miRNAs provides an explanation for the increased expression
of p53 in these cells. If this down regulation of miR-125b and miR-
150 are confirmed along with increased p53 in the post mortem
brains of HD, then it may explain the cause for elevated p53 and
its role in HD pathogenesis as observed in other studies [4,10,11].
NFkB is known to resist apoptosis induction [54,55] while p53
in general, is a well-known inducer of apoptosis. Thus down
regulation of RelA/NFkB and increased expression of p53 as
observed in STHdh
Q111/Hdh
Q111 cells, a cell model of HD, if
replicated in HD patients could be one of the mechanisms of
enhanced apoptosis observed in HD as reviewed by Imarisio et al.,
2008 [1]. The differential pattern of expression of the two
transcription factors NFkB and p53 in STHdh
Q111/Hdh
Q111 cells,
prompted us to search for any relationship that might exist
between the expressions of these two transcription factors. We
observed an inverse correlation between the levels of p53 and p65
sub-unit of NFkB (RelA/NFkB) in neuronal cells. Exogenous
expression of p53 and stabilization of p53 by 5-FU treatment
decreased the expression of RelA/NFkB and activity of NFkB.
Reducing the expression of p53 either by siRNA or by expressing
exogenous miR-150 increased NFkB activity as detected by the
luciferase assay. It is unclear what exactly mediates such functional
inverse relationship. CREB binding protein (CBP) is known to
interact with both p53 and RelA/NFkB and depending on the
preference either induces or prevents apoptosis. Sequestration of
CBP to p53 may decrease NFkB activity [38]. Activated p53 is also
known to induce NFkB DNA binding but at the same time
suppresses its transcriptional activation [37]. This may provide an
explanation for the decreased NFkB activity as observed in our
studies. However, there is a report, which suggests for an
activation of the transcription factor NFkB in response to apoptosis
induced by p53 [41]. Besides, RelA/NFkB is also known to
regulate p53 expression in tumor cells in response to hypoxia [56].
All these results show that p53 directly or indirectly regulates
RelA/NFkB expression and activity of NFkB and thus the
expression of miR-146a. The other possibility of direct interfer-
ence of p53 on miR-146a expression could not be ruled out and
requires further studies. Even though it is conceivable that p53 can
modulate the activity of NFkB, how the expression of RelA/NFkB
is compromised remains unknown.
Chaperones are known to protect mutant HTT aggregates
possibly by preventing formation of aggregates. We have earlier
shown that HYPK possesses chaperone like activity and reduces
the aggregates formed by mutated N-terminal HTT coded by
exon1 of the gene [45]. Exogenous expression of N-terminal
HTT with 83Q increased the mutant HTT aggregates as have
been observed by many authors including us [44]. In such
condition, p53 expression was increased and RelA/NFkB
expression was decreased (Figure 9A) similar to that obtained
in endogenous STHdh
Q111/Hdh
Q111 cells when compared with
endogenous STHdh
Q7/Hdh
Q7 cells. NFkB activity and expression
of miR-146a, miR-125b and miR-150 were also reduced in such
condition (Figures 9B and 9C). However, co-expression of
HYPK together with mutant HTT exon1 reduced the aggregates,
reduced p53 expression and recovered the activity of NFkB and
miR-146a, miR-125b and miR-150 expressions (Figures 10A–
10D). Similar results were also observed with Hsp70. Results
obtained with STHdh
Q111/Hdh
Q111 cells, a cell model of HD has
been schematically represented in Figure 12 to propose for a
probable model showing the involvement of RelA/NFkB, p53
and miRNAs in the regulation of cell death in HD pathogenesis.
The model shows that mutant HTT modulates the expression of
p53 and p65 subunit of NFkB (RelA/NFkB), NFkB activity and
miR-146a, miR-125b and miR-150 expressions. Since miR-125b
and miR-150 target p53, we postulate that in the presence of
mutant HTT aggregates there is an initial decrease in miR-125b
and miR-150 expression. These down regulated miRNAs lead to
increased p53 level as observed in presence of aggregates. The
elevated p53 then in turn, further increases mutant HTT
aggregates and decreases RelA/NFkB expression, NFkB activity
and miR-146a expression.
In summary, we may conclude that in STHdh
Q111/Hdh
Q111 cells,
down regulation of miR-146a is mediated through RelA/NFkB.
Increased p53 level in HD models could be mediated through
down regulation of miR-125b and miR-150. p53 directly or
indirectly regulates the expression of miR-146a. Identification of
interplay between transcription factors and miRNAs regulating
their targets remains one of the challenges in miRNA biology. Our
investigation using HD cell lines provides important observations
that miR-146a is regulated by p53 and RelA/NFkB and increased
p53 could be mediated through down regulation of miR-125b and
miR-150. It requires further studies to establish if such regulation
plays any role in HD pathogenesis.
Materials and Methods
R6/2 mice
Ovarian transplanted hemizygote females carrying HD exon 1
gene with about 150 CAG repeats (strain name: B6CBA-
Tg(Hdexon1)62Gpb/3J) were purchased from Jackson Labora-
tory and crossed with B6CBAF1/J males. The transgenic strain
was maintained by crossing carrier males with CBA females. The
genotyping was carried out using PCR as described previously by
Mangirani et al., 1996 [47]. All animal experiments were
performed according to the protocol approved by the Institu-
tional Animal Ethics Committee of National Brain Research
Centre, Manesar. Animals had free access to pelleted diet and
water ad libitum. All efforts were made to minimize animal
suffering. The transgenic mice along with their age-matched
controls were anesthetized and then perfused with PBS
containing 4% PFA in PBS, brain samples were collected and









Q7 cells express full-length wild type HTT with
7Q (homozygous) while STHdh
Q111/Hdh
Q111 cells express full
length mutated HTT with 111Q (homozygous) from the
chromosomal region and is considered as a model for HD. These
cell lines were established from wild type and homozygous mutant
Hdh knock in embryonic mice respectively [32]. Dr. Marcy E.
MacDonald of Massachusetts General Hospital, USA, kindly
provided these cells to us. STHdh
Q111/Hdh
Q111 cells exhibit
dominant HD phenotypes and indicate a disruption of striatal
cell homeostasis by the mutant HTT protein, via a mechanism
that is different from its normal activity (STHdh
Q7/Hdh
Q7 cells).
This cell model of HD has been extensively used for identifying
molecular alterations in HD [57–64].
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Q111 cells, obtained from
Dr. Marcy E. MacDonald, were cultured in DMEM (HiMedia,
India) supplemented with 10% (v/v) heat inactivated FBS
(Biowest, France), antibiotics penicillin/streptomycin PS 1% (v/
v) and 400 mg/ml G418 (Invitrogen, USA) at 33uC in humidified
condition and 5% CO2. HeLa cells were cultured in MEM
(HiMedia, India), 10% (v/v) FBS (Biowest, France), 1% (v/v) PS at
37uC in humidified condition and 5% CO2. Growth conditions for
HeLa cells [44] and growth conditions for Neuro2a cells [45] were
similar to those which have already been published. Human
derived neuroblastoma cells SH-SY5Y were cultured in DMEM
(HiMedia, India), 10% (v/v) FBS (Biowest, France), 1% (v/v) PS at
37uC in humidified condition and 5% CO2.
Antibodies and materials
Anti-p53 monoclonal antibody (1:200, Clone DO7, Imgenex,
USA) was used for immuno-precipitation. Anti-p53 polyclonal
(1:2000, Clone DO7, Imgenex, USA), anti-p65 monoclonal
(1:1000, MAB3026, Chemicon, USA), anti-GFP monoclonal
(1:4000, CATALOG No. 632375, Clontech, USA) and anti-b-
actin monoclonal (1:10,000, A2228, Sigma Chemicals, USA)
antibodies were used for immunoblot analysis. Anti-HYPK
polyclonal was custom made by providing purified HYPK
protein [45] to Imgenex Biotech Pvt. Ltd, India (1:1000, CP 40
07, Imgenex Biotech Pvt. Ltd, India). Anti-mouse IgG-HRP
(1:8,000) and anti-rabbit IgG-HRP (1:6000) were purchased from
GENEI, India and used as secondary antibodies. Aspirin was
purchased from Central Drug House Laboratory Reagent, India
and 5-Fluorouracil (5-FU) obtained from Sigma-Aldrich, USA
was used.
DNA constructs
Precursor miRNA-125b (Chr11: 121970465–121970552, - strand)
and precursor miRNA-150 (Chr19: 50004042–50004125, - strand)
were amplified by PCR from human genomic DNA and respectively
cloned into pU61 Hygro (Genescript, USA) vector using BamHI and




CCCCATGGCCCTGTCT-39 and miR_150_U6_R: 59-CCC-
AAGCTTAAAAAGTCCCCAGGTCCCTGTCC-39. Full-length
human p53 cDNA was obtained by PCR from human brain cDNA
library and cloned into CFP vector using BamH1 and Sal1 sites. The
primers used for cloning were p53_CFP_F: 59-ACGCGTCGA-
CGTGGAGCCGCAGTCAGATCCTA-39 and p53_CFP_R: 59-
CGCGGATCCCAGTCTGAGTCAGGCCCTTC-39. Full-length
p65 subunit of NFkB (RelA), cloned into pLG3 vector was obtained
as a kind gift from Dr. Susanta Roychoudhury, IICB, Kolkata. For
knocking down p53, pSuppressorNeo p53 plasmid DNA containing
p53 siRNA [65] construct (Imgenex, USA) was used.
For luciferase reporter assays, we cloned two fragments of the 39
UTR of human p53 into pmiR-Report vector (Ambion, USA),
one comprising of 150 bp (position 733–739) containing miR-
125b recognition site and the other comprising of 136 bp (position
Figure 12. Proposed model for the involvement of RelA/NFkB, p53 and microRNAs in the regulation of cell death in HD
pathogenesis. The model shows that mutant HTT modulates the expression of both p53 and p65 subunit of NFkB (RelA/NFkB) expression and
activity and miR-146a, miR-125b and miR-150 expressions. Since miR-125b and miR-150 target p53, we postulate that in the presence of mutant HTT
aggregates there is an initial decrease in miR-125b and miR-150 expression. These down regulated miRNAs lead to increased p53 level as observed in
presence of aggregates. The elevated p53 then in turn, further increases mutant HTT aggregates and decreases NFkB/p65 expression (RelA/NFkB),
NFkB activity and miR-146a expression.
doi:10.1371/journal.pone.0023837.g012
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amplified by PCR from human genomic DNA and cloned in
vector using the MluI and HindIII (NEB, USA) sites. The
constructs were named p53-UTR1 and p53-UTR2 respectively.
For NFkB1 (p50), 213 bp (position 145–359) of the 39 UTR of
NFkB1 containing no predicted recognition site for either miR-
125b or miR-150 was cloned into the vector using SpeI and MluI
(NEB) sites and was named p50-UTR. The following primers were




39 and p53-UTR2-R: 59-CCCAAGCTTAAGTGGGCCCCTA-
CCTAGAA-39; p50-UTR-F: 59-GGACTAGTTTGGCTTCC-
TTTCTTGGTTC-39 and p50-UTR-R: 59-CGACGCGTGGC-
GACCGTGATACCTTTAAT-39. For functional assay of NFkB
promoter, the plasmids NFkB luciferase, containing multiple
copies of NFkB response elements (NFkB-RE) and Gastrin
luciferase containing the promoter sequence of Gastrin cloned in
pGL3 vector were obtained as a kind gift from Prof. Susanta
Roychoudhury, IICB, Kolkata.
In order to induce poly Q mediated aggregation in STHdh
Q7/
Hdh
Q7 cells, Neuro2a cells, SH-SY5Y cells and HeLa cells, N-
terminal HTT with 83Q coded by exon1 of the gene cloned into
Ds Red-C1 vector was used. For removal of such aggregates with
the help of chaperones in STHdh
Q7/Hdh
Q7 cells, DNA constructs
containing full-length Hsp70 cloned into EGFP-C1 vector and N
terminal of HYPK also cloned into EGFP-C1 vectors were used.
For control experiments, empty vectors DsRedC1 and pEGFPC1
(both from BD Biosciences, USA) were used.
RNA preparation
Total RNA was prepared from cultured cells using TriZol
Reagent (Invitrogen, USA) according to manufacturer’s protocol.
RNA samples were quantitated using Biophotometer (Eppendorf,
Germany).
RNA extraction from paraffin embedded tissue samples
RNA was isolated from tissue sections routinely processed by
fixation and paraffin embedding that does not completely degrade
RNAs. Further, it is suggested that RNA fragments of around 100
bases in length or more are still present even in organs fixed at
later stages after removal and also in organs very rich in RNase
such as the pancreas [66]. We isolated RNA from paraffin
embedded tissue samples of R6/2 mice following the protocol
described by Santa et al., 1998, Korbler et al., 2003 [67,68]. Using
this method many investigators studied expressions of coding
sequences of DNA like b-actin, Ikaros and Aliolos from
paraffinised lymph node sections of patients with malignant
disorders of the lymphopoietic system (Hodgkin’s and non-
Hodgkin’s lymphoma) [68]. There have been previous reports of
studies on miRNA expression patterns from total RNA isolated
from formalin-fixed paraffin-embedded (FFPE) tissues and frozen
cells [69,70,71].
In brief, isolation method for RNA from paraffin embedded
tissues consists of the following steps: De-paraffinization: For RNA
extraction from tissue sections obtained from R62 mice, two
sections each of 20 mm thickness were taken per 1.5 ml eppendorf
tube. The sections were deparaffinised by two rinses in xylene for
5 min each at room temperature followed by two centrifugations
at room temperature for 10 min each at 10,000 g. Rehydration:
After paraffin solubilization, a rehydration step was introduced
where the supernatants from the previous step were carefully
removed and the pellets were successively washed with 1 ml of
absolute ethanol and 1 ml of 95% ethanol in DEPC water. After
each step the tissue was collected by centrifugation at 10,000 g for
10 min. Protein digestion: After the final wash, alcohol was
aspirated and the tissue pellets were air dried in a thermoblock at
37uC and re-suspended in 500 ml of digestion buffer (10 mM
NaCl, 500 mM Tris, pH 7.6, 20 mM EDTA and 1% SDS). To
obtain purified RNA, tissue proteins were removed by adding
500 mg/ml of the proteolytic enzyme proteinase K. The sections
were then incubated at 45uC for 16 hours (overnight). Prior to
RNA purification, proteinase K was inactivated at 100uC for
7 min in order to nullify its effects on PCR. RNA extraction: Total
RNA was then extracted from these tissue sections by using Trizol
reagent and following manufacturer’s protocol. Concentrations of
total RNA was measured and total RNA was used to measure
expression levels of genes like b-actin (contol), p53 and RelA/
NFkB (p65 sub-unit of NFkB) and microRNAs like miR-150, miR-
125b, miR-146a and miR-17-5p after making the cDNA.
Quantitative real time for miRNAs and their analysis
For Real time quantitation of microRNA, 100 ng of total RNA
was taken for cDNA preparation using mirna specific stem-loop
primers (ABI), Mulv-Reverse transcriptase (Fermentas), RNase
inhibitor (Fermentas) and dNTPs. cDNA was then subjected to the
procedure as described in [33]. We earlier confirmed miR-17-5p
expression to remain unaltered in various conditions and cells





Q111 cells and thus it was used as an endogenous control in our
laboratory [33]. Besides, miR-17-5p has also been found to be
useful as a suitable endogenous control in other studies as well
[72]. In the present work also the expression of miR-17-5p was
found to remain unchanged in various conditions and cells used.
Thus, miR-17-5p was used as endogenous control to calculate fold
change in all RT-PCR studies. The fold changes were calculated
in accordance with SDS software V 2.0.
Real time PCR for mRNAs analysis
For real time of mRNAs 1 mg of total RNA was subjected to
DNase treatment (Sigma) followed by cDNA preparation using
random hexamer primer (Fermentas), dNTPs and MuLv- Reverse
transcriptase (Fermentas) following the procedure described in
[33]. The primers used for RT-PCR were: p53_expression_F: 59-
TCCCCCTTGCCGTCCCAA-39, p53_expression_R: 59-CGT-
GCAAGTCACAGACTT-39; RelA(mse)_expression_F: 59-GGC-
CTCATCCACATG- AACTT-39, RelA(mse)_expression_R: 59-
CACTGTCACCTGGAAGCAGA-39; and Actin-b_F: 59-TC-
CTGTGGCATCCACGA- AACT-39, Actin-b_R: GAAGCAT-
TTGCGGTGGAC. Yield of the PCR products was estimated
from the integrated optical density (IOD) using Image Master
VDS software (Amersham Bioscience, UK). Data show mRNA
expression levels relative to those of b-actin; the former was then
normalized to control expression levels for each experiment.
Luciferase assays





Q111 cells were plated the day before transfection at 5610
4 cells
per well in 24-well plates (Nunc, USA). The following day, 50 ng
of p53-39UTR in pmiR-Report luciferase vector was transfected
into cells using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. 24 hours later, luciferase assays were
performed (Sirius Luminometer, Berthold detection systems, USA)
using Luciferase Reporter assay system (Promega) according to the
manufacturer’s protocol. 3 mg of total protein was taken for each
assay. Transfection efficiency was normalized by co-transfecting
cells with GFP-C1 and measuring the Fluoresence at 510 nm
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cells were normalized to the activity of empty vector (pmiR-Report
luciferase vector), to nullify difference in protein synthesis levels





cells. The experiments were carried out in triplicate. For over
expression studies, 200 ng of pmiR-Report with desired clone and
300 ng of cloned pre-miR-125b or pre- miR-150 were co-
transfected and luciferase assay was done following the same
procedure.










Q111 cells were plated a
day before transfection per well in 6-well plates. The following
day, 1 mg of NFkB response element construct and Gastrin
luciferase construct were separately transfected. 24 h or 48 h
post transfection, cells were collected and luciferase assays were
performed as discussed above. For inhibiting NFkB activity, cells
were treated with 2 mM aspirin 24 hours prior to transfection.
For over expression studies 1 mgo fp 5 3 - C F Pa n d1mgo fe m p t y
vector (CFP) were separately co-transfected with NFkB response
element construct in STHdh
Q7/Hdh
Q7 cells and for knocking
down p53, 1 mg of p53 siRNA construct was transfected in
HeLa cells (data not shown) and STHdh
Q7/Hdh
Q7 cells and 1 mg
of miR-150 was transfected in STHdh
Q111/Hdh
Q111 cells along
with 1 mg of NFkB luciferase construct. Luciferase assay was
performed in each case following the same procedure as
discussed above.
Immunoblot analysis
Cells were washed with cold phosphate-buffered saline (PBS),
scraped, pelleted by centrifugation and lysed on ice for 30 mins
using RIPA lysis buffer (50 mM Tris-HCl pH 8, 1% NP40,
150 mM NaCl, 12 mM deoxycholic acid sodium salt, 0.1% SDS)
with protease inhibitor cocktail (Thermo Scientific, USA). The
supernatant collected after centrifugation (at 4uC for 15 min at
18,000 g) was estimated by Bradford assay (BioRad, Hercules, CA)
according to manufacturer’s protocol. The OD readings of the
samples were measured at 595 nm in Biophotometer (Eppendorf).
For immunoblots 30 or 60 mg of total protein, boiled in SDS
PAGE sample buffer were run on 10% SDS-PAGE, transferred to
PVDF membranes (Thermo Scientific, USA) and detected by
immunoblottting with the indicated antibodies. Integrated optical
density (IOD) of each band compared to individual loading
control was measured using Image Master VDS software
(Amersham Biosciences, UK).
Co-immunoprecipitation assay
For co-immunoprecipitation assay, cells washed in cold PBS
were lysed in co-immunoprecipitation (co-IP) buffer (50 mM Tris,
pH 8.0, 150 mM NaCl, 1% NP40 and complete protease
inhibitor cocktail) for 1 hour at 4uC with gentle mixing on an
eppendorf rotor. Cell lysates were then centrifuged at 16,000 g for
15 min at 4uC and 50 mg of supernatant (total soluble extract) was
used as an input for immunoprecipitation. For each experiment,
200 mg of the supernatant in 200 ml co-IP buffer was pre-cleared
with agarose-protein G beads (GENEI, Bangalore, India) at 4uC
for 2 hours with gentle shaking and then centrifuged at 1000 g for
5 min at 4uC. The beads obtained were washed twice with co-IP
buffer, boiled in SDS PAGE loading buffer and used as negative
antibody. The supernatant obtained was incubated overnight with
1 mg of p53 antibody at 4uC with gentle shaking. Next day,
agarose-protein G bead was added to it and kept shaking for
6 hours at 4uC. The beads were precipitated by centrifuging at
18,000 g for 15 min at 48C, washed thrice by co-immunoprecip-
itation buffer, boiled with SDS–PAGE loading buffer and run on
10% SDS–PAGE and analyzed by immunoblotting technique
with anti-p65 antibody.
Statistical analysis
Statistical analysis was done with the help of Graphpad
Software, QuickCalcs, (http://www.graphpad.com/quickcalcs/
index.cfm). Student’s t-test was performed between control and
experimental values to determine their statistical significance.
Supporting Information
Figure S1 (A) hsa-miR-150 binds to the 39UTR of human
p53. The position (234–256) in human p53-39UTR predicted by
miRBase as the recognition site for hsa-miR-150. Texts in blue
indicate the ‘seed’ region. (B). mmu-miR-125b binds to the
39UTR of mouse Trp53. (I) The position (413–435) in mouse
p53-39UTR predicted by RNAhybrid as the recognition site for
mmu-miR-125b. Texts in blue indicate the ‘seed’ region. Their
predicted stable RNA-RNA duplex formed by the binding of miR-
125b to the 39UTR of mouse Trp53 is shown in panel (II). The
RNA strand in green represents mmu-miR-125b and the RNA
strand in brown represents 413–435 of the 39UTR in the mouse
Trp53 transcript. (C). mmu-miR-150 binds to the 39UTR of
mouse Trp53. (I) The position (260–287) in mouse p53-39UTR
predicted by RNAhybrid as the recognition site for mmu-miR-
150. Texts in blue indicate the ‘seed’ region. Their predicted stable
RNA-RNA duplex formed by the binding of miR-150 to the
39UTR of mouse Trp53 is shown in panel (II). The RNA strand in
green represents mmu-miR-150 and the RNA strand in brown
represents 260–287 of the 39UTR in the mouse Trp53 transcript.
(TIF)
Table S1 MicroRNA expression changes in 83Q DsRed
transfected cells compared to controls. Expressions of
several miRNAs were studied in striatal regions of the brains of
R6/2 mice and in four different cell lines exogenously expressing
N-terminal HTT with 83Q coded by the exon1 of HTT gene and
the results thus obtained have been indicated in the table. miR-17-
5p was taken as endogenous control and fold change greater than
1.5 was considered as deregulated. The results obtained were
compared with those found in HD cell model [33]. Texts in bold
show names of miRNAs which maintained similar trend in their
individual expression pattern in at least four of the six different
models used for comparison. miR-125b and miR-150 were down
regulated by more than 1.5 fold in five of the models including
R6/2 mice whereas miR-146a was down regulated in all the
models. Other miRNAs which showed a consistent expression
pattern across the models were miR-100, miR-214, miR-299,
miR-335, miR-34a and miR-148a. However, miR-148a which
was up regulated in HD cell model [33] had been shown to be
down regulated in all other models. The remaining miRNAs
which were deregulated in HD cell model [33] have however
showed heterogeneity in their expression pattern across the various
models. The results obtained indicate that despite differences in
miRNA expressions in various models, miR-146a, miR-125b and
miR-150 were preferentially down regulated than others in the
presence of poly Q aggregates.
(TIF)
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